Impaired endothelin-induced vasoconstriction in coronary arteries of Zucker obese rats is associated with uncoupling of [Ca2+]i signaling

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 290, Issue 1, 2006, Pages

  Katakam, Prasad V G ^a   Snipes, James A ^a   Tulbert, Christina D ^a   Mayanagi, Keita ^a   Miller, Allison W ^a   Busija, David W ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Endothelial nitric oxide synthase; Insulin resistance

Indexed keywords

CALCIUM ION; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; N(G) NITROARGININE METHYL ESTER; PROSTAGLANDIN F2 ALPHA; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONCENTRATION (PARAMETERS); CORONARY ARTERY CONSTRICTION; INSULIN RESISTANCE; MUSCLE FIBRIL; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; ANIMAL; CALCIUM SIGNALING; CORONARY BLOOD VESSEL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASOCONSTRICTION; ZUCKER RAT;

ANIMALS; CALCIUM SIGNALING; CORONARY VESSELS; DINOPROST; ENDOTHELIN-1; GENE EXPRESSION REGULATION; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OBESITY; RATS; RATS, ZUCKER; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; VASOCONSTRICTION;

EID: 33644833757     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00405.2005     Document Type: Article

References (44)

1. 2 mimetic U46619 interaction, in type-2 hypertensive diabetic Zucker rats. Diabetes Res Clin Pract 63: 155-169, 2004.
2. Awazu M, Parker RE, Harvie BR, Ichikawa I, and Kon V. Downregulation of endothelin-1 receptors by protein kinase C in streptozotocin diabetic rats. J Cardiovasc Pharmacol 17, Suppl 7: S500-S502, 1991.
3. Boulanger C and Luscher TF. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 85: 587-590, 1990.
4. Cannan CR, Mathew V, and Lerman A. New insight into coronary endothelial dysfunction: role of endothelin. J Lab Clin Med 131: 300-305, 1998.
5. Centers for Disease Control and Prevention Primary Prevention Working Group. Primary prevention of type 2 diabetes mellitus by lifestyle intervention: implications for health policy. Ann Intern Med 140: 951-957, 2004.
6. Dumont AS, Dumont RJ, McNeill JH, Kassell NF, Sutherland GR, and Verma S. Chronic endothelin antagonism restores cerebrovascular function in diabetes. Neurosurgery 52: 653-660, 2003.
7. Erdos B, Miller AW, and Busija DW. Impaired endothelium-mediated relaxation in isolated cerebral arteries from insulin-resistant rats. Am J Physiol Heart Circ Physiol 282: H2060-H2065, 2002.
8. Erdos B, Snipes JA, Kis B, Miller AW, and Busija DW. Vasoconstrictor mechanisms in the cerebral circulation are unaffected by insulin resistance. Am J Physiol Regul Integr Comp Physiol 287: R1456-R1461, 2004.
9. Erdos B, Snipes JA, Miller AW, and Busija DW. Cerebrovascular dysfunction in Zucker obese rats is mediated by oxidative stress and protein kinase C. Diabetes 53: 1352-1359, 2004.
10. Erdos B, Snipes JA, Tulbert CD, Katakam PV, Miller AW, and Busija DW. Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H-oxidase-dependent superoxide production. Am J Physiol Heart Circ Physiol. In press.
11. i in contraction of coronary arteries from DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol 282: H1944-H1949, 2002.
12. Giulumian AD, Pollock DM, Clarke N, and Fuchs LC. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats. Am J Physiol Regul Integr Comp Physiol 274: R1613-R1618, 1998.
13. 13 in agonist-induced vascular smooth muscle cell contraction. Circ Res 87: 221-227, 2000.
14. Goligorsky MS, Tsukahara H, Magazine H, Andersen TT, Malik AB, and Bahou WF. Termination of endothelin signaling: role of nitric oxide. J Cell Physiol 158: 485-494, 1994.
15. Hopfner RL and Gopalakrishnan V. Endothelin: emerging role in diabetic vascular complications. Diabetologia 42: 1383-1394, 1999.
16. A receptor expression in rat aortic smooth muscle cells. Diabetes 47: 937-944, 1998.
17. Hopfner RL, McNeill JR, and Gopalakrishnan V. Vanadate treatment normalizes exaggerated vascular smooth muscle responses in the obese Zucker rat. Eur J Pharmacol 357: 61-65, 1998.
18. Hopfner RL, Misurski DA, McNeill JR, and Gopalakrishnan V. Effect of sodium orthovanadate treatment on cardiovascular function in the hyperinsulinemic, insulin-resistant obese Zucker rat. J Cardiovasc Pharmacol 34: 811-817, 1999.
19. Karagiannis J, Reid JJ, Darby I, Roche P, Rand MJ, and Li CG. Impaired nitric oxide function in the basilar artery of the obese Zucker rat. J Cardiovasc Pharmacol 42: 497-505, 2003.
20. Katakam PV, Pollock JS, Pollock DM, Ujhelyi MR, and Miller AW. Enhanced endothelin-1 response and receptor expression in small mesenteric arteries of insulin-resistant rats. Am J Physiol Heart Circ Physiol 280: H522-H527, 2001.
21. Katakam PV, Tulbert CD, Snipes JA, Erdos B, Miller AW, and Busija DW. Impaired insulin-induced vasodilation in small coronary arteries of Zucker obese rats is mediated by reactive oxygen species. Am J Physiol Heart Circ Physiol 288: H854-H860, 2005.
22. Kis B, Snipes A, Bari F, and Busija DW. Regional distribution of cyclooxygenase-3 mRNA in the rat central nervous system. Brain Res Mol Brain Res 126: 78-80, 2004.
23. 2+ responses and tyrosine phosphorylation in coronary smooth muscle. J Cardiovasc Pharmacol 40: 18-27, 2002.
24. 2+ signaling, tyrosine phosphorylation, and coronary artery disease in diabetic dyslipidemic swine are prevented by atorvastatin. J Pharmacol Exp Ther 306: 132-140, 2003.
25. McAuley DF, Nugent AG, McGurk C, Maguire S, Hayes JR, and Johnston GD. Vasoconstriction to endogenous endothelin-1 is impaired in patients with type II diabetes mellitus. Clin Sci (Lond) 99: 175-179, 2000.
26. McFarlane SI, Banerji M, and Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 86: 713-718, 2001.
27. i signaling in microvessels of DOCA-salt hypertensive rats. J Hypertens 20: 1799-1805, 2002.
28. Nugent AG, McGurk C, Hayes JR, and Johnston GD. Impaired vasoconstriction to endothelin 1 in patients with NIDDM. Diabetes 45: 105-107, 1996.
29. Oliver FJ, de la Rubia G, Feener EP, Lee ME, Loeken MR, Shiba T, Quertermous T, and King GL. Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem 266: 23251-23256, 1991.
30. 2+ handling in the aorta of Zucker obese rats with insulin resistance. Diabetes 45, Suppl 3: S55-S58, 1996.
31. Phillips SA, Sylvester FA, and Frisbee JC. Oxidant stress and constrictor reactivity impair cerebral artery dilation in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 288: R522-R530, 2005.
32. Pollock DM, Keith TL, and Highsmith RF. Endothelin receptors and calcium signaling. FASEB J 9: 1196-1204, 1995.
33. Shaw LM, Ohanian J, and Heagerty AM. Calcium sensitivity and agonist-induced calcium sensitization in small arteries of young and adult spontaneously hypertensive rats. Hypertension 30: 442-448, 1997.
34. Shipley RD, and Muller-Delp JM. Aging decreases vasoconstrictor responses of coronary resistance arterioles through endothelium-dependent mechanisms. Cardiovasc Res 66: 374-383, 2005.
35. 2+ entry mechanisms of vascular contraction are enhanced during high-salt diet. Hypertension 41: 787-793, 2003.
36. Stepp DW and Frisbee JC. Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 282: H816-H820, 2002.
37. Subramanian R and MacLeod KM. Age-dependent changes in blood pressure and arterial reactivity in obese Zucker rats. Eur J Pharmacol 477: 143-152, 2003.
38. Tickerhoof MM, Farrell PA, and Korzick DH. Alterations in rat coronary vasoreactivity and vascular protein kinase C isoforms in type 1 diabetes. Am J Physiol Heart Circ Physiol 285: H2694-H2703, 2003.
39. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment, and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998.
40. Verma S, Arikawa E, Lee S, Dumont AS, Yao L, and McNeill JH. Exaggerated coronary reactivity to endothelin-1 in diabetes: reversal with bosentan. Can J Physiol Pharmacol 80: 980-986, 2002.
41. 2+ signaling in diabetic dyslipidemia. J Vasc Res 39: 208-220, 2002.
42. Wang QD, Gonon A, Shimizu M, Sjoquist PO, and Pernow J. Contribution of endothelin to the coronary vasoconstriction in the isolated rat heart induced by nitric oxide synthase inhibition. Acta Physiol Scand 163: 325-330, 1998.
43. Wu SQ, Hopfner RL, McNeill JR, Wilson TW, and Gopalakrishnan V. Altered paracrine effect of endothelin in blood vessels of the hyperinsulinemic, insulin resistant obese Zucker rat. Cardiovasc Res 45: 994-1000, 2000.
44. Zanchi A, Delacretaz E, Taleb V, Gaillard R, Jeanrenaud B, Brunner HR, and Waeber B. Endothelial function of the mesenteric arteriole and mechanical behavior of the carotid artery in rats with insulin resistance and hypercholesterolaemia. J Hypertens 13: 1463-1470, 1995.